1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Spyroulias, G.A. Nikolakopoulou, P. Tzakos, A. Gerothanassis, I.P. Magafa, V. Manessi-Zoupa, E. Cordopatis, P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 270 2163 2173 10.1046/j.1432-1033.2003.03573.x 12752436 Comparison of the solution structures of angiotensin I & II. Implication for structure-function relationship. 2003 US J.Biol.Chem. JBCHA3 0071 0021-9258 269 5303 5312 Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 1299.499 Angiotensin I 1 syn polymer Ang I no no DRVYIHPFHL DRVYIHPFHL A polypeptide(L) n n n n n n n n n n repository Initial release Version format compliance Version format compliance Structure summary 1 0 2003-07-29 1 1 2008-04-28 1 2 2011-07-13 1 3 2016-12-21 RCSB Y RCSB 2002-11-26 REL THE PEPTIDE WAS made through Solid phase synthesis using Fmoc chemistry. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN homo sapiens. sample This structure was determined using standard 2D homonuclear techniques. Models 1-20 are the family ensemble, while model 21 is the minimized average structure derived from that ensemble. target function for models 1-20, mean energy minimized for model 21 300 21 DQF-COSY 2D TOCSY 2D NOESY ambient 298 K This structure is based on a 225 NOE-derived distance constraints, 7 dihedral angle restraints, 1 distance restraint from hydrogen bond simulated annealing, torsion angle dynamics 21 2.5 mM; DMSO-d6 DMSO-d6 collection XWINNMR 2.6 processing XWINNMR 2.6 Tai-he Xia, Christian Bartels, Kurt Wuthtrich data analysis XEASY 1.3 Peter Guntert, Christian Mumenthaler, Kurt Wuthrich structure solution DYANA 1.5 KOLLMAN, CASE, MERZ, CHEATHAM, SIMMERLING, DARDEN, PEARLMAN refinement AMBER 5.0 400 Bruker DPX ASP 1 n 1 ASP 1 A ARG 2 n 2 ARG 2 A VAL 3 n 3 VAL 3 A TYR 4 n 4 TYR 4 A ILE 5 n 5 ILE 5 A HIS 6 n 6 HIS 6 A PRO 7 n 7 PRO 7 A PHE 8 n 8 PHE 8 A HIS 9 n 9 HIS 9 A LEU 10 n 10 LEU 10 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 14 A ARG 2 0.097 SIDE CHAIN 1 A PHE 8 -171.75 117.36 1 A HIS 9 -149.53 58.75 2 A PHE 8 -171.58 118.30 2 A HIS 9 -146.96 56.59 3 A PHE 8 -171.58 118.30 3 A HIS 9 -146.96 56.59 4 A PHE 8 -171.72 119.30 4 A HIS 9 -151.55 64.97 5 A PHE 8 -171.89 117.86 6 A PHE 8 -171.07 118.93 6 A HIS 9 -148.27 58.33 7 A PHE 8 -172.11 119.21 7 A HIS 9 -148.35 59.63 8 A PHE 8 -170.91 117.84 8 A HIS 9 -151.10 65.66 9 A PHE 8 -171.91 118.31 10 A PHE 8 -170.43 119.85 11 A PHE 8 -171.77 118.80 12 A PHE 8 -171.48 120.14 13 A PHE 8 -172.61 118.31 14 A PHE 8 -171.25 119.07 14 A HIS 9 -151.60 58.30 15 A PHE 8 -171.72 117.20 16 A PHE 8 -171.92 117.45 16 A HIS 9 -151.34 63.70 17 A PHE 8 -171.81 119.55 17 A HIS 9 -153.46 61.79 18 A PHE 8 -172.14 119.22 18 A HIS 9 -149.75 57.10 19 A PHE 8 -171.24 118.47 19 A HIS 9 -150.37 63.29 20 A PHE 8 -170.95 115.71 20 A HIS 9 -153.52 35.98 21 A PHE 8 -170.23 122.61 21 A HIS 9 -153.61 59.70 Angiotensin I Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structure-Function Relationship 1 N N SIGNALING PROTEIN Angiotensin, Renin-Angiotensin System, Solid Phase Peptide Synthesis, NMR Solution Structure, Peptides, SIGNALING PROTEIN ANGT_HUMAN UNP 1 34 P01019 DRVYIHPFHL 34 43 1N9U 1 10 P01019 A 1 1 10